XL Capital Ltd Issues Statement Regarding Merrill Lynch Lawsuit Against XL Capital Assurance Inc. (XLCA) a Subsidiary of Security Capital Assurance Ltd

HAMILTON, Bermuda, June 10 XL Capital Ltd(NYSE: XL) (the "Company") announced today that it is not involved in asummary judgment handed down by the U.S. District Court for the SouthernDistrict of New York in favor of Merrill Lynch International. Merrill LynchInternational filed a complaint against Security Capital Assurance Ltd's(NYSE: SCA) subsidiary, XL Capital Assurance Inc. (XLCA), relating to certaincredit default swap transactions entered into by trusts and insured by XLCAfollowing SCA's IPO in August 2006. XLCA is not a subsidiary of XL CapitalLtd.

The swaps at issue in the lawsuit were entered into by XLCA after SCA'sIPO. XL Insurance (Bermuda) Ltd's reinsurance guarantee to a subsidiary of SCAapplies only to pre-IPO exposures.

Pursuant to a transition agreement entered into at the time of SCA's IPO,SCA is permitted to use the "XL" name until August 2008. XL owns approximately46% of the common equity interest of SCA. As the above dispute is betweenMerrill Lynch International and XLCA, any queries regarding the lawsuit shouldbe referred directly to the parties involved in the lawsuit.

Further information regarding XL's relationship with SCA may be found inXL's filings with the Securities and Exchange Commission.

XL Capital Ltd, through its operating subsidiaries, is a leading providerof global insurance and reinsurance coverages to industrial, commercial andprofessional service firms, insurance companies and other enterprises on aworldwide basis. As of March 31, 2008, XL Capital Ltd had consolidated assetsof $54.8 billion and consolidated shareholders' equity of $9.3 billion. Moreinformation about XL Capital Ltd is available at www.xlcapital.com.

SOURCE XL Capital Ltd

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...